Literature DB >> 20568389

Omalizumab monotherapy for bee sting and unprovoked "anaphylaxis" in a patient with systemic mastocytosis and undetectable specific IgE.

Kalliopi Kontou-Fili, Christos I Filis, Christina Voulgari, Panayiotis G Panayiotidis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20568389     DOI： 10.1016/j.anai.2010.04.011

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  9 in total

1.  Omalizumab: A useful tool for inducing tolerance to bee venom immunotherapy.

Authors:  L Ricciardi
Journal:  Int J Immunopathol Pharmacol       Date:  2016-09-27       Impact factor: 3.219

Review 2.  Biologic modulators in allergic and autoinflammatory diseases.

Authors:  Lori Broderick; Louanne M Tourangeau; Arthur Kavanaugh; Stephen I Wasserman
Journal:  Curr Opin Allergy Clin Immunol       Date:  2011-08

Review 3.  Update on diagnosis and treatment of mastocytosis.

Authors:  Knut Brockow; Johannes Ring
Journal:  Curr Allergy Asthma Rep       Date:  2011-08       Impact factor: 4.806

Review 4.  Use of omalizumab in the treatment of food allergy and anaphylaxis.

Authors:  Jay A Lieberman; Mirna Chehade
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

5.  Cutaneous and gastrointestinal symptoms in two patients with systemic mastocytosis successfully treated with omalizumab.

Authors:  Sofie Lieberoth; Simon Francis Thomsen
Journal:  Case Rep Med       Date:  2015-01-28

Review 6.  Targeted Treatment Options in Mastocytosis.

Authors:  Mélanie Vaes; Fleur Samantha Benghiat; Olivier Hermine
Journal:  Front Med (Lausanne)       Date:  2017-07-20

7.  Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis.

Authors:  Noelia Dasilva-Freire; Andrea Mayado; Cristina Teodosio; María Jara-Acevedo; Iván Álvarez-Twose; Almudena Matito; Laura Sánchez-Muñoz; Carolina Caldas; Ana Henriques; Javier I Muñoz-González; Andrés C García-Montero; J Ignacio Sánchez-Gallego; Luis Escribano; Alberto Orfao
Journal:  Int J Mol Sci       Date:  2019-01-28       Impact factor: 5.923

Review 8.  Pharmacological treatment options for mast cell activation disease.

Authors:  Gerhard J Molderings; Britta Haenisch; Stefan Brettner; Jürgen Homann; Markus Menzen; Franz Ludwig Dumoulin; Jens Panse; Joseph Butterfield; Lawrence B Afrin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-30       Impact factor: 3.000

Review 9.  Precision Medicine in Hymenoptera Venom Allergy: Diagnostics, Biomarkers, and Therapy of Different Endotypes and Phenotypes.

Authors:  Simon Blank; Johannes Grosch; Markus Ollert; Maria Beatrice Bilò
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.